Pharmacogenomic analysis and clinical annotation of 635 patients
Such a high frequency of critical variants (51%) points to the need for pharmacogenetic studies. The results are extremely important in terms of determining the drug dose according to the genomic status of individuals receiving drug therapy and preventing unnecessary health expenditures.
Authors
- Nadir Koçak (ORCID: https://orcid.org/0000-0002-1727-1582)
- Tülin Çora (ORCID: https://orcid.org/0000-0001-9787-7519)
- Ebru Marzioğlu Özdemir (ORCID: https://orcid.org/0000-0001-5125-2855)
- Özkan Bağcı (ORCID: https://orcid.org/0000-0002-9896-6764)
- Batuhan Şanlıtürk (ORCID: https://orcid.org/0000-0003-4583-6066)
Institutions
- Selçuk University (TR)
Publication Details
- Journal
- Personalized Medicine
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1080/17410541.2025.2493606
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00